MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with S

Sodium phenylbutyrate

Sodium phenylbutyrate 5mg capsules

No stability information

Stability notes for Sodium phenylbutyrate 5mg capsules

There are no stability notes for this medicine.

Supplier

Sodium phenylbutyrate 5mg capsules (Special Order)

Sodium phenylbutyrate 483mg/g granules

No stability information

Stability notes for Sodium phenylbutyrate 483mg/g granules

There are no stability notes for this medicine.

Supplier

Pheburane 483mg/g granules (Eurocept International bv)

Sodium phenylbutyrate 500mg capsules

No stability information

Stability notes for Sodium phenylbutyrate 500mg capsules

There are no stability notes for this medicine.

Supplier

Sodium phenylbutyrate 500mg capsules (Special Order)

Sodium phenylbutyrate 500mg tablets

Incompatible

Stability notes for Sodium phenylbutyrate 500mg tablets

Product is hygroscopic, therefore unsuitable for MCA.

Provenance

This compatibility recommendation is derived from Ammonaps 500mg tablets (Immedica Pharma AB).

Supplier

Ammonaps 500mg tablets (Immedica Pharma AB)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.